Clinical risk factors for invasive aspergillosis

References

• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, . Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415.
   PubMed Web of Science ®Google Scholar
• Rello J, Esandi ME, Mariscal D, . Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26:1473–1475.
   PubMed Web of Science ®Google Scholar
• Vandewoude K, Blot S, Benoit D, . Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clinica Belgica 2004; 59: 251–257.
   PubMed Web of Science ®Google Scholar
• Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin N America 2002; 16: 875–894.
   PubMed Web of Science ®Google Scholar
• Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007; 67: 1567–1601.
   PubMed Web of Science ®Google Scholar
• Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519–531.
   PubMed Web of Science ®Google Scholar
• Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin N America 2003; 17: 113–134.
   PubMed Web of Science ®Google Scholar
• Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006; 63: 246–254.
   PubMed Web of Science ®Google Scholar
• Martino R, Subira M, Rovira M, . Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002; 16: 475–482.
   Google Scholar
• Kontoyiannis DP, Chamilos G, Lewis RE, . Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 2007; 110: 1303–1306.
   PubMed Web of Science ®Google Scholar
• Altes A, Remacha AF, Sarda P, . Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505–509.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45: 205–216.
   PubMed Web of Science ®Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007; 30: 782–800.
   PubMed Web of Science ®Google Scholar
• Guinea J, Torres-Narbona M, Gijon P, . Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect 2009; Nov 10 (e-pub ahead of print).
   PubMed Web of Science ®Google Scholar
• Denning DW. Aspergillosis in ‘nonimmunocompromised’ critically ill patients. Am J Resp Crit Care Med 2004; 170: 580–581.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006; 12: 1060–1076.
   PubMed Web of Science ®Google Scholar
• Jensen J, Guinea J, Torres-Narbona M, Munoz P, . Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity. J Infect 2010; 60: 162–167.
   PubMed Web of Science ®Google Scholar
• Holding KJ, Dworkin MS, Wan PC, . Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and adolescent spectrum of HIV disease project. Clin Infect Dis 2000; 31: 1253–1257.
   PubMed Web of Science ®Google Scholar
• Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83: 181–194.
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckth M, Corey L. Invasive aspergillosis in alogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358–4366.
   PubMed Web of Science ®Google Scholar
• Ullmann AJ, Lipton JH, Vesole DH, . Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335–347.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Barosi G, Aversa F, . Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009; 49: 1226–1236.
   PubMed Web of Science ®Google Scholar
• Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459–1466.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47: 1041–1050.
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917.
   PubMed Web of Science ®Google Scholar
• Martino R, Pinana JL, Parody R, . Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2009; 44: 749–756.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, . Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
   PubMed Web of Science ®Google Scholar
• Singh N, Avery RK, Munoz P, . Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46–52.
   PubMed Web of Science ®Google Scholar
• Husain S, Tollemar J, Dominguez EA, . Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023–2029.
   PubMed Web of Science ®Google Scholar
• Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007; 45: 305–320.
   PubMed Web of Science ®Google Scholar
• Singh N, Husain S. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9: S180–191.
   Google Scholar
• Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123–138.
   PubMed Web of Science ®Google Scholar
• Fortun J. Infections related to intravascular devices used for infusion therapy. Enfermedades Infecciosas Microbiol Clin 2008; 26: 168–174.
   PubMed Web of Science ®Google Scholar
• Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis 2002; 4(Suppl. 3): 24–31.
   PubMedGoogle Scholar
• Munoz P, Alcala L, Sanchez Conde M, . The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 2003; 75: 326–329.
   PubMed Web of Science ®Google Scholar
• Gavalda J, Len O, San Juan R, . Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005; 41: 52–59.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Vandecasteele SJ, Wilmer A, . Invasive aspergillosis in critically ill patients without malignancy. Am J Resp Crit Care Med 2004; 170: 621–625.
   PubMed Web of Science ®Google Scholar
• Cornillet A, Camus C, Nimubona S, . Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577–584.
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, . Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Resp Crit Care Med 2008; 177: 27–34.
   PubMed Web of Science ®Google Scholar
• Heinemann S, Symoens F, Gordts B, Jannes H, Nolard N. Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. J Hosp Infect 2004; 57: 149–155.
   PubMed Web of Science ®Google Scholar
• Ader F, Nseir S, Le Berre R, . Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005; 11: 427–429.
   PubMed Web of Science ®Google Scholar
• Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007; 33: 1694–1703.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Kirkpatrick WR, White M, . Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine 2000; 79: 250–260.
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, . Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: 191–199.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
   PubMed Web of Science ®Google Scholar
• Bobba RK, Arsura EL. Aspergillus infection in a hospitalised veteran population. Clin Microbiol Infect 2004; 10: 679.
   PubMed Web of Science ®Google Scholar
• Rodrigues J, Niederman MS, Fein AM, Pai PB. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93: 29–34.
   PubMed Web of Science ®Google Scholar
• Tong KB, Lau CJ, Murtagh K, Layton AJ, Seifeldin R. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. Int J Infect Dis 2009; 13: 24–36.
   PubMed Web of Science ®Google Scholar
• Miller WT, Jr., Sais GJ, Frank I, . Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994; 105: 37–44.
   PubMed Web of Science ®Google Scholar
• Denning DW, Follansbee SE, Scolaro M, . Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 654–662.
   PubMed Web of Science ®Google Scholar
• Wallace JM, Lim R, Browdy BL, . Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 1998; 114: 131–137.
   PubMed Web of Science ®Google Scholar
• Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992; 14: 141–148.
   PubMed Web of Science ®Google Scholar
• Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38: 1261–1265.
   PubMed Web of Science ®Google Scholar
• Filler SG, Yeaman MR, Sheppard DC. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 2005; 41: S208–212.
   PubMed Web of Science ®Google Scholar
• Manz M, Beglinger C, Vavricka SR. Fatal invasive pulmonary aspergillosis associated with adalimumab therapy. Gut 2009; 59: 149.
   Google Scholar
• Salavert M, Bastida G, Peman J, Nos P. Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy. Rev Iberoam Micol 2009; 26: 213–217.
   PubMed Web of Science ®Google Scholar